This is a preview of subscription content, access via your institution
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Döhner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373:1136–52.
Thomas D, Majeti R. Biology and relevance of human acute myeloid leukemia stem cells. Blood. 2017;129:1577–85.
Angelini DF, Ottone T, Guerrera G, Lavorgna S, Cittadini M, Buccisano F, et al. A leukemia-associated CD34/CD123/CD25/CD99+immunophenotype identifies FLT3-mutated clones in acute myeloid Leukemia. Clin Cancer Res. 2015;21. https://doi.org/10.1158/1078-0432.CCR-14-3186.
Travaglini S, Angelini DF, Alfonso V, Guerrera G, Lavorgna S, Divona M, et al. Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells. Blood Cancer J. 2020;10:85.
Manara MC, Pasello M, Scotlandi K. CD99: a cell surface protein with an oncojanus role in tumors. Genes. 2018;9. https://doi.org/10.3390/genes9030159.
Travaglini S, Angelini DF, Alfonso V, Guerrera G, Lavorgna S, Divona M, et al. Characterization of FLT3-ITD(mut) acute myeloid leukemia: molecular profiling of leukemic precursor cells. Blood Cancer J. 2003;21:759–806.
Ottone T, Zaza S, Divona M, Hasan SK, Lavorgna S, Laterza S, et al. Identification of emerging FLT3 ITD-positive clones during clinical remission and kinetics of disease relapse in acute myeloid leukaemia with mutated nucleophosmin. Br J Haematol. 2013;161:533–40.
Hahn JH, Kim MK, Choi EY, Kim SH, Sohn HW, Ham DI, et al. CD99 (MIC2) regulates the LFA-1/ICAM-1-mediated adhesion of lymphocytes, and its gene encodes both positive and negative regulators of cellular adhesion. J Immunol. 1997;159:2250–8.
Vaikari VP, Du Y, Wu S, Zhang T, Metzeler K, Batcha AMN, et al. Clinical and preclinical characterization of CD99 isoforms in acute myeloid leukemia. Haematologica. 2020;105:999–1012.
Chung SS, Bernard G, Lollini P-L, Nanni P, Zuntini M, Landuzzi L, et al. CD99 is a therapeutic target on disease stem cells in myeloid malignancies. Sci Transl Med. 2017;17:1910–21.
Tavakkoli M, Chung SS, Park CY. Do preclinical studies suggest that CD99 is a potential therapeutic target in acute myeloid leukemia and the myelodysplastic syndromes? Expert Opin Ther Targets. 2018;22:381–3.
Scotlandi K, Zuntini M, Manara MC, Sciandra M, Rocchi A, Benini S, et al. CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity. Oncogene. 2007;26:6604–18.
Costello RT, Mallet F, Gaugler B, Sainty D, Arnoulet C, Gastaut J-A, et al. Human acute myeloid Leukemia CD34+/CD38− progenitor cells have decreased sensitivity to chemotherapy and fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. Cancer Res. 2000;60:4403 LP–4411.
This work was supported by AIRC 5 × 1000 call “Metastatic disease: the key unmet need in oncology” to MYNERVA project, #21267 (MYeloid NEoplasms Research Venture AIRC. A detailed description of the MYNERVA project is available at http://www.progettoagimm.it.), by GR-2018-12365529-Santa Lucia to TO, by PRIN grant N. 2017WXR7ZT to MTV, by Ministero della Salute, Rome, Italy (Finalizzata 2018, NET-2018-12365935, Personalized medicine program on myeloid neoplasms: characterization of the patient’s genome for clinical decision making and systematic collection of real world data to improve quality of health care) to MTV and AIRC IG 2018 - ID. 21406 project to FF
The authors declare no competing interests.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Travaglini, S., Ottone, T., Angelini, D.F. et al. CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITDmut AML. Leukemia 36, 1685–1688 (2022). https://doi.org/10.1038/s41375-022-01566-5